Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Pinnacle Clinical Research Acquires Five Clinical Trial Sites
LongueVue Capital, a New Orleans-based private equity firm, announce that its portfolio company Pinnacle Clinical Research has completed successful investments in five clinical trial sites in Texas, New Jersey and South Carolina. Pinnacle has invested in Kerwin Medical Center (KMC), The Cognitive and Research Center of New Jersey (CRCNJ), Bellaire Clinical Research, Palmetto Clinical Research – Low Country and Dallas Research Institute. Headquartered in Dallas, Texas and founded in 2019, KMC is a leading clinical research network operating one site in Dallas. The company is currently opening another site in South Dallas. CRCNJ, headquartered in Springfield, New Jersey, is a central nervous... Read More »
TPG Invests in K2 Medical Research
On June 17 TPG announced that it was making a significant growth investment in K2 Medical Research. K2 Medical Research is a leading clinical research organization (CRO) dedicated to advancing medical science through the efficient and ethical conduct of clinical trials. Its integrated clinical trial site platform specializes in central nervous system trials for leading pharma and biotech sponsor and is focused around complex therapeutic areas including Alzheimer’s, psychiatry and liver disease. The company is based in Florida and operates seven locations across the state. TPG is a global alternative asset management firm with $137 billion of assets under management and... Read More »
Sidekick Health Expands Oncology and Women’s Health Portfolio With PINK!
Sidekick Health has announced the acquisition of PINK!, a pioneering digital health company specializing in cancer support and women’s health. This acquisition enhances Sidekick Health’s portfolio and strengthens its position in the digital therapeutics market. PINK! operates a physician-led online platform for breast cancer patients, offering digital therapeutics. The health-tech startup from Hamburg developed PINK! Coach, the first and only breast cancer app permanently approved as a DiGA (app on prescription). This app serves as a digital companion for breast cancer patients, providing scientifically-based medical information and guidance. Founded in 2020, PINK! employs 27... Read More »
Boston Scientific Acquires Silk Road Medical in California
Boston Scientific announced on June 18 the acquisition of Silk Road Medical, located in Sunnyvale, California. Boston Scientific said it would pay $27.50 per share for Silk Road, totaling $1.16 billion. The California company’s shares were priced at $26.84 at midday Tuesday. Silk Road Medical is a medical device company that is focused on reducing the risk of stroke and its impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery... Read More »
Remote Patient Monitoring May Continue Growth Trend for the Rest of the Decade
Consistent annual growth in deal volume has characterized the remote patient monitoring (RPM) market in recent years. Projections throughout much of the rest of the decade support the possibility that the trend will continue. According to MarketsandMarkets, the size of the global RPM market in terms of revenue was estimated to be worth $71.9 billion in 2023 and is poised to reach $207.5 billion by 2028, growing at a compound annual growth rate of 23.6 percent from 2023 to 2028. RPM allows patients to be monitored for specific health conditions and can prevent complications for those who can’t easily travel, according to telehealth.hhs.gov. Symptoms and conditions that can be tracked... Read More »
Blue Arch Capital Acquires Medical Outpatient Building for $15.25 Million
Avison Young, a global real estate broker, announced on June 17 that Blue Arch Capital acquired a medical outpatient building (MOB) in Silver Spring, Maryland for $15.25 million. Doctors Medical Park consists of three buildings and totals approximately 98,000 square feet. It is spread over 4.8 acres of land and is situated about a mile north of Holy Cross Hospital. The complex’s current tenants include Community Radiology Associates, Fresenius, Capital Women’s Care and The Ladas Eye Group. The price is roughly $156 per-square-foot. Blue Arch Capital is a real estate private equity firm that acquires and operates core-plus and value-add properties in the United States. It is... Read More »
Specialized Dental Partners Acquires Two Dental Practices
Specialized Dental Partners (SDP) announced that it acquired two dental practices: Eastlake Endodontics and BC Perio. Eastlake Endodontics has one location in Roy, Utah. According to its website, it has two providers on staff: Dr. Jonathan Richards and Dr. Michelle Howe. BC Perio, based in Dallas, Texas, is run by Dr. Brad Crumps, who is supported by a team of eight employees. The practice specializes in treating periodontal disease as well as surgical treatments for dental issues. A portfolio company of private equity group Quad-C Management, SDP is a leading specialty dental service organization that provides comprehensive support services to endodontic specialists... Read More »
Interview with Robert Aprill, Physician Growth Partners
We are always interested in the opinion of advisors, and other industry experts, regarding the Physician Medical Group (PMG) market. So, we put out a pulse survey to get a better feel of the current environment. From this survey, we spoke with Robert Aprill, Partner at Physician Growth Partners, to get his perspective on the market. How optimistic are you about the future of the PMG market within the next year or two? “I think there’s two forces at play so it’s a little bit of a complex answer. There’s going to be more Owners interested in selling and there’s going to be a lot of Buyers that are spooked by higher interest rates and broader headwinds in the PPM space. Physicians... Read More »
Siegfried Acquires Curia Global’s Early-Phase Manufacturing Site
Siegfried announced on June 13 that it was expanding its global contract development management organization (CDMO) abilities with the acquisition of an early-phase manufacturing site in Grafton, Wisconsin from Curia Global. The Wisconsin facility specializes in early-phase development and manufacturing services and employs more than 80 workers. Siegfried develops and manufactures active pharmaceutical ingredients for pharmaceutical clients with R&D programs, related intermediates and controlled substances. Siegfried also offers the development and production of finished dosage forms, including sterile fillings. It is based in Zofingen, Switzerland. Curia Global is a... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
